Prevalence of tobacco use in selected Johannesburg suburbs

J. A. Teare; N. Naicker; P. Albers; A. Mathee

doi:10.7196/samj.2017.v108i1.12283

Prevalence of tobacco use in selected Johannesburg suburbs

J. A. Teare^*, N. Naicker, P. Albers, A. Mathee

^*Corresponding author for this work

Bristol Medical School (PHS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

3 Citations (Scopus)

Abstract

Background. Tobacco smoking is estimated to kill more than 44 000 South Africans every year. Studies have shown that since the introduction of tobacco control measures, national smoking prevalence has declined in South Africa (SA). Objective. To determine the prevalence of tobacco smoking over a 7-year period in five impoverished neighbourhoods in Johannesburg, SA. Methods. Data were collected through the annual administration of a prestructured questionnaire to one adult respondent in preselected dwellings from 2006 to 2012. Information was collected on socioeconomic status, smoking practices and health status. Results. Over the 7-year period of the analysis, smoking levels remained unchanged. The proportion of households with one or more smokers varied significantly across the five study neighbourhoods. Approximately 20% of households in Hillbrow and as many as 77% in Riverlea had a member who smoked. Conclusions. Despite a national downward trend in smoking levels, tobacco use remains high and persistent in certain vulnerable communities, requiring scaled-up action to reduce the risk of a range of tobacco-related diseases.

Original language	English
Pages (from-to)	40-44
Number of pages	5
Journal	South African Medical Journal
Volume	108
Issue number	1
DOIs	https://doi.org/10.7196/samj.2017.v108i1.12283 https://doi.org/10.7196/SAMJ.2018.v108i1.12283
Publication status	Published - Jan 2018

Bibliographical note

Funding Information:
The ACERCA study was sponsored by the Spanish Society of Nephrology (S.E.N.) with an unrestricted grant from Roche Pharma Spain. AMC declare that has received research support from Amgen, Abbott, Boehringer-Ingelheim and Roche, as well as honoraria for participating in advisory boards from Abbvie, Amgen, Boehringer-Ingelheim, Esteve, Janssen-Cilag, Novartis and Roche. AC has received research support from Amgen and Roche. He has received honoraria for participating in advisory boards from Roche, Amgen, Pfizer, Novartis, Abbott, Astra-Zeneca and received speaker fees from Roche, Amgen, Johnson and Johnson, Bristol Myers Squibb, Novartis, Pfizer, Almirall, Esteve, Astra-Zeneca, Siemens. Others authors declare that they have no competing interests.

Publisher Copyright:
© 2018, South African Medical Association. All rights reserved.

Keywords

Tobacco smoking
Johannesburg
South Africa

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Handle.net

Persistent link

Cite this

@article{455c2118f4744a7e872e87e99e49173e,

title = "Prevalence of tobacco use in selected Johannesburg suburbs",

abstract = "Background. Tobacco smoking is estimated to kill more than 44 000 South Africans every year. Studies have shown that since the introduction of tobacco control measures, national smoking prevalence has declined in South Africa (SA). Objective. To determine the prevalence of tobacco smoking over a 7-year period in five impoverished neighbourhoods in Johannesburg, SA. Methods. Data were collected through the annual administration of a prestructured questionnaire to one adult respondent in preselected dwellings from 2006 to 2012. Information was collected on socioeconomic status, smoking practices and health status. Results. Over the 7-year period of the analysis, smoking levels remained unchanged. The proportion of households with one or more smokers varied significantly across the five study neighbourhoods. Approximately 20% of households in Hillbrow and as many as 77% in Riverlea had a member who smoked. Conclusions. Despite a national downward trend in smoking levels, tobacco use remains high and persistent in certain vulnerable communities, requiring scaled-up action to reduce the risk of a range of tobacco-related diseases.",

keywords = "Tobacco smoking, Johannesburg, South Africa",

author = "Teare, {J. A.} and N. Naicker and P. Albers and A. Mathee",

note = "Funding Information: The ACERCA study was sponsored by the Spanish Society of Nephrology (S.E.N.) with an unrestricted grant from Roche Pharma Spain. AMC declare that has received research support from Amgen, Abbott, Boehringer-Ingelheim and Roche, as well as honoraria for participating in advisory boards from Abbvie, Amgen, Boehringer-Ingelheim, Esteve, Janssen-Cilag, Novartis and Roche. AC has received research support from Amgen and Roche. He has received honoraria for participating in advisory boards from Roche, Amgen, Pfizer, Novartis, Abbott, Astra-Zeneca and received speaker fees from Roche, Amgen, Johnson and Johnson, Bristol Myers Squibb, Novartis, Pfizer, Almirall, Esteve, Astra-Zeneca, Siemens. Others authors declare that they have no competing interests. Publisher Copyright: {\textcopyright} 2018, South African Medical Association. All rights reserved.",

year = "2018",

month = jan,

doi = "10.7196/samj.2017.v108i1.12283",

language = "English",

volume = "108",

pages = "40--44",

journal = "South African Medical Journal",

issn = "0256-9574",

publisher = "South African Medical Association",

number = "1",

}

TY - JOUR

T1 - Prevalence of tobacco use in selected Johannesburg suburbs

AU - Teare, J. A.

AU - Naicker, N.

AU - Albers, P.

AU - Mathee, A.

N1 - Funding Information: The ACERCA study was sponsored by the Spanish Society of Nephrology (S.E.N.) with an unrestricted grant from Roche Pharma Spain. AMC declare that has received research support from Amgen, Abbott, Boehringer-Ingelheim and Roche, as well as honoraria for participating in advisory boards from Abbvie, Amgen, Boehringer-Ingelheim, Esteve, Janssen-Cilag, Novartis and Roche. AC has received research support from Amgen and Roche. He has received honoraria for participating in advisory boards from Roche, Amgen, Pfizer, Novartis, Abbott, Astra-Zeneca and received speaker fees from Roche, Amgen, Johnson and Johnson, Bristol Myers Squibb, Novartis, Pfizer, Almirall, Esteve, Astra-Zeneca, Siemens. Others authors declare that they have no competing interests. Publisher Copyright: © 2018, South African Medical Association. All rights reserved.

PY - 2018/1

Y1 - 2018/1

N2 - Background. Tobacco smoking is estimated to kill more than 44 000 South Africans every year. Studies have shown that since the introduction of tobacco control measures, national smoking prevalence has declined in South Africa (SA). Objective. To determine the prevalence of tobacco smoking over a 7-year period in five impoverished neighbourhoods in Johannesburg, SA. Methods. Data were collected through the annual administration of a prestructured questionnaire to one adult respondent in preselected dwellings from 2006 to 2012. Information was collected on socioeconomic status, smoking practices and health status. Results. Over the 7-year period of the analysis, smoking levels remained unchanged. The proportion of households with one or more smokers varied significantly across the five study neighbourhoods. Approximately 20% of households in Hillbrow and as many as 77% in Riverlea had a member who smoked. Conclusions. Despite a national downward trend in smoking levels, tobacco use remains high and persistent in certain vulnerable communities, requiring scaled-up action to reduce the risk of a range of tobacco-related diseases.

AB - Background. Tobacco smoking is estimated to kill more than 44 000 South Africans every year. Studies have shown that since the introduction of tobacco control measures, national smoking prevalence has declined in South Africa (SA). Objective. To determine the prevalence of tobacco smoking over a 7-year period in five impoverished neighbourhoods in Johannesburg, SA. Methods. Data were collected through the annual administration of a prestructured questionnaire to one adult respondent in preselected dwellings from 2006 to 2012. Information was collected on socioeconomic status, smoking practices and health status. Results. Over the 7-year period of the analysis, smoking levels remained unchanged. The proportion of households with one or more smokers varied significantly across the five study neighbourhoods. Approximately 20% of households in Hillbrow and as many as 77% in Riverlea had a member who smoked. Conclusions. Despite a national downward trend in smoking levels, tobacco use remains high and persistent in certain vulnerable communities, requiring scaled-up action to reduce the risk of a range of tobacco-related diseases.

KW - Tobacco smoking

KW - Johannesburg

KW - South Africa

UR - http://www.scopus.com/inward/record.url?scp=85038357762&partnerID=8YFLogxK

U2 - 10.7196/samj.2017.v108i1.12283

DO - 10.7196/samj.2017.v108i1.12283

M3 - Article (Academic Journal)

SN - 0256-9574

VL - 108

SP - 40

EP - 44

JO - South African Medical Journal

JF - South African Medical Journal

IS - 1

ER -

Prevalence of tobacco use in selected Johannesburg suburbs

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this